[-2]PROPSA PREDICTS BIOPSY RECLASSIFICATION IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER

被引：0
|
作者：
Tosoian, Jeffrey
Isharwal, Sumit
Feng, Zhaoyong
Makarov, Danil
Landis, Patricia
Veltri, Robert
Trock, Bruce
Epstein, Jonathan
Partin, Alan
Sokoll, Lori
Carter, H. B.
Loeb, Stacy
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.2570
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2323
引用
收藏
页码：E931 / E932
页数：2
相关论文
共 50 条
  • [1] Association of [-2]proPSA with Biopsy Reclassification During Active Surveillance for Prostate Cancer
    Tosoian, Jeffrey J.
    Loeb, Stacy
    Feng, Zhaoyong
    Isharwal, Sumit
    Landis, Patricia
    Elliot, Debra J.
    Veltri, Robert
    Epstein, Jonathan I.
    Partin, Alan W.
    Carter, H. Ballentine
    Trock, Bruce
    Sokoll, Lori J.
    JOURNAL OF UROLOGY, 2012, 188 (04): : 1131 - 1136
  • [2] [-2]PROPSA PREDICTS PATHOLOGICAL RECLASSIFICATION IN PATIENTS UNDERGOING REPEAT BIOPSY 1 YEAR AFTER ACTIVE SURVEILLANCE FOR LOW RISK PROSTATE CANCER
    Hirama, Hiromi
    Sugimoto, Mikio
    Kakehi, Yoshiyuki
    JOURNAL OF UROLOGY, 2013, 189 (04): : E914 - E914
  • [3] Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active Surveillance
    Druskin, Sasha C.
    Mamawala, Mufaddal
    Tosoian, Jeffrey J.
    Epstein, Jonathan I.
    Pavlovich, Christian P.
    Carter, H. Ballentine
    Trock, Bruce J.
    JOURNAL OF UROLOGY, 2019, 201 (01): : 98 - 104
  • [4] Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active Surveillance EDITORIAL COMMENT
    Sternberg, Itay A.
    JOURNAL OF UROLOGY, 2019, 201 (01): : 104 - 104
  • [5] APPARENT DIFFUSION COEFFICIENT PREDICTS RISK OF GRADE RECLASSIFICATION IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Huang, Mitchell
    Landis, Patricia
    Epstein, Jonathan
    Macura, Katarzyna
    Carter, H. Ballentine
    Mamawala, Mufaddal
    JOURNAL OF UROLOGY, 2018, 199 (04): : E139 - E139
  • [6] PROSTATE HEALTH INDEX IN PREDICTING GRADE RECLASSIFICATION ON BIOPSY FOR MEN ON ACTIVE SURVEILLANCE
    Filson, Christopher
    Sokoll, Lori
    Zheng, Yingye
    Huang, Yijian
    Newcomb, Lisa
    Zhu, Kehao
    Williams, Sierra
    Sanda, Martin
    Chan, Daniel
    Lin, Daniel
    JOURNAL OF UROLOGY, 2021, 206 : E1095 - E1096
  • [7] Identifying Men Who Can Remain on Active Surveillance Despite Biopsy Reclassification to Grade Group 2 Prostate Cancer
    Baraban, Ezra
    Erak, Eric
    Fatima, Aisha
    Akbari, Amir
    Zhao, Jianping
    Fletcher, Sean A.
    Bhanji, Yasin
    de la Calle, Claire M.
    Mamawala, Mufaddal
    Landis, Patricia
    Macura, Katarzyna J.
    Pavlovich, Christian P.
    Epstein, Jonathan I.
    JOURNAL OF UROLOGY, 2023, 210 (01): : 99 - 107
  • [8] Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer Reply
    不详
    JOURNAL OF UROLOGY, 2020, 204 (06): : 1221 - 1221
  • [9] Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer
    Kirk, Peter S.
    Zhu, Kehao
    Zheng, Yingye
    Newcomb, Lisa F.
    Schenk, Jeannette M.
    Brooks, James D.
    Carroll, Peter R.
    Dash, Atreya
    Ellis, William J.
    Filson, Christopher P.
    Gleave, Martin E.
    Liss, Michael
    Martin, Frances
    McKenney, Jesse K.
    Morgan, Todd M.
    Nelson, Peter S.
    Thompson, Ian M.
    Wagner, Andrew A.
    Lin, Daniel W.
    Gore, John L.
    CANCER, 2022, 128 (02) : 269 - 274
  • [10] Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
    Andreas, Darian
    Tosoian, Jeffrey J.
    Landis, Patricia
    Wolf, Sacha
    Glavaris, Stephanie
    Lotan, Tamara L.
    Schaeffer, Edward M.
    Sokoll, Lori J.
    Ross, Ashley E.
    UROLOGY CASE REPORTS, 2016, 7 : 64 - 66
12345